ImmunoPrecise Antibodies Ltd (IPA)

0.4001 -0.02 (-4.76%) USD  |  NASDAQ  |  Dec 20, 16:00
0.4014 0.00 (0.00%) After-Hours: 20:00
More

ImmunoPrecise Antibodies Debt to Equity Ratio: 0.0947 for Oct. 31, 2024

Debt to Equity Ratio Chart

View Debt to Equity Ratio for IPA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Debt to Equity Ratio Definition

View Debt to Equity Ratio Definition
Start Trial

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Aurinia Pharmaceuticals Inc 0.00
Edesa Biotech Inc --
Lexaria Bioscience Corp 0.00
Xenon Pharmaceuticals Inc --
ESSA Pharma Inc --

Debt to Equity Ratio Related Metrics

Total Assets (Quarterly) 43.11M
Total Liabilities (Quarterly) 19.62M
Shareholders Equity (Quarterly) 23.49M
Current Ratio 1.008
Net Debt Paydown Yield -3.08%